Reach Us +1-217-403-9671
Editor - Carlos Rubio Terres | Health Economics & Research of Ou | 19019
ISSN 2472-1042

Pharmacoeconomics: Open Access
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences

33rd World Congress on Pharmacology

Barcelona, Spain
Share This Page

Carlos Rubio Terres

Carlos Rubio Terres
Carlos Rubio Terrés
Director of Health Value


Carlos Rubio Terres is Director of HEALTH VALUE, Health Economics & Research of Outcomes Consulting, in Madrid, Spain. He holds a master’s degree in Pharmacology from the University of Barcelona, a degree in Pharmacoeconomics from the National School of Public Health in Madrid, and a bachelors degree in Biological sciences from the University Autonoma of Madrid, Spain. Over the past three decades he has held various positions in the fields of drugs evaluation and pharmacoeconomics, including Technical advisor at the Pharmacobiology National Centre, Instituto de Salud Carlos III, and the Drug Evaluation Unit, Ministry of Health, Madrid, Spain. He has also served as a member of the Committee for Proprietary Medicinal Products (CPMP) on behalf of the Spanish Ministry of Health, in Brussels. He holds various positions (Regulatory Affairs Manager, Scientific Services Manager, Pharmacoeconomics Manager) in a number of pharmaceutical companies (Lederle, Wyeth, Aventis). Carlos Rubio Terres is currently a reviewer for numerous medical and economic journals, including the British Medical Journal, and a member of the Editorial Committee of Pharmacoeconomics Spanish Research Articles (Adis International) and the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Speakers Bureau. He has published 225 articles in peer-reviewed journals and book chapters on pharmacoeconomics, meta-analysis, decision analysis, regulatory affairs, clinical trials, statistical design of health research, pharmacology and toxicology, and numerous communications and posters at conferences.

Research Interest

Health economics modelling, Meta-analysis, Drug evaluation.



Global Speakers in the subject

Global Experts in the subject